Update on survival in osteosarcoma
ME Anderson - Orthopedic Clinics, 2016 - orthopedic.theclinics.com
Survival in osteosarcoma is a story of success on many fronts. What was once a disease that
was rarely curable even with ablative surgery now has a 5-year overall survival approaching …
was rarely curable even with ablative surgery now has a 5-year overall survival approaching …
[HTML][HTML] Osteosarcoma: a multidisciplinary approach to diagnosis and treatment
JC Wittig, J Bickels, D Priebat, J Jelinek… - American family …, 2002 - aafp.org
The treatment of osteosarcoma requires a multidisciplinary approach involving the family
physician, orthopedic oncologist, medical oncologist, radiologist and pathologist …
physician, orthopedic oncologist, medical oncologist, radiologist and pathologist …
Osteosarcoma: cells‐of‐origin, cancer stem cells, and targeted therapies
A Abarrategi, J Tornin, L Martinez-Cruzado… - Stem cells …, 2016 - Wiley Online Library
Osteosarcoma (OS) is the most common type of primary solid tumor that develops in bone.
Although standard chemotherapy has significantly improved long‐term survival over the past …
Although standard chemotherapy has significantly improved long‐term survival over the past …
Palliative therapy for osteosarcoma
C Errani, A Longhi, G Rossi, E Rimondi… - Expert review of …, 2011 - Taylor & Francis
Despite advances in diagnostic imaging, the evolution of neoadjuvant chemotherapy and
the refinements in limb-salvage surgery, the progression-free survival rate remains poor for …
the refinements in limb-salvage surgery, the progression-free survival rate remains poor for …
A review of clinical and molecular prognostic factors in osteosarcoma
JCM Clark, CR Dass, PFM Choong - Journal of cancer research and …, 2008 - Springer
Traditional prognostic determinants in osteosarcoma have included demographics (age,
sex), tumour size, site, stage, and the response to chemotherapy. Many of these are …
sex), tumour size, site, stage, and the response to chemotherapy. Many of these are …
Biology and therapeutic advances for pediatric osteosarcoma
N Marina, M Gebhardt, L Teot, R Gorlick - The oncologist, 2004 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to: Discuss
etiologic and biologic factors in osteosarcoma. Select the appropriate diagnostic work-up for …
etiologic and biologic factors in osteosarcoma. Select the appropriate diagnostic work-up for …
Biology of osteogenic sarcoma
LL Wang - The Cancer Journal, 2005 - journals.lww.com
Osteosarcoma is the most common primary malignant bone tumor in children and
adolescents. Despite significant clinical improvements over the past several decades …
adolescents. Despite significant clinical improvements over the past several decades …
[HTML][HTML] Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment
Y Jiang, J Wang, M Sun, D Zuo, H Wang… - Nature …, 2022 - nature.com
Osteosarcoma (OS) is a primary malignant bone tumor that most commonly affects children,
adolescents, and young adults. Here, we comprehensively analyze genomic, epigenomic …
adolescents, and young adults. Here, we comprehensively analyze genomic, epigenomic …
Emerging next-generation sequencing-based discoveries for targeted osteosarcoma therapy
J Zhao, DC Dean, FJ Hornicek, X Yu, Z Duan - Cancer letters, 2020 - Elsevier
Osteosarcoma (OS) is the most common primary bone malignancy and is frequently lethal
via metastasis to the lung. While surgical techniques and adjuvant chemotherapies have …
via metastasis to the lung. While surgical techniques and adjuvant chemotherapies have …
Molecular genetics of osteosarcoma
K Rickel, F Fang, J Tao - Bone, 2017 - Elsevier
Osteosarcoma is the predominant form of bone cancer, affecting mostly adolescents. Recent
progress made in molecular genetic studies of osteosarcoma has changed our view on the …
progress made in molecular genetic studies of osteosarcoma has changed our view on the …